Product Launch (Blog)

Mar, 03 2022

Global Ocular Pain Market is Growing with a CAGR of 6.5% in the Forecast Period of 2021 to 2028

The Global Ocular Pain Market is growing with increasing unhygienic and sedentary lifestyles, rising prevalence of ophthalmic disorders, and ocular pain. Increasing awareness among people for eye-related diseases also acts as a major factor for the market's growth. Growing cases of ocular migraine have also given a boom to the global ocular pain market.

However, the side effects of eye treatment medicines and the high cost of eye treatment and medication have decreased the market demand.

Global Ocular Pain Market Scenario                                        

According to Data Bridge Market Research, the market for global ocular pain in North America has the highest market share, followed by Europe and Asia-Pacific. The market leader is Bausch & Lomb Incorporated, which accounts for approximately 5.54% of the market share in the global ocular pain market. The company has gained outstanding sales by providing novel ocular pain products.

  • In July 2021, Bausch & Lomb Incorporated announced on their website that they launched Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelid Cleansing Wipes. These products are preservative-free and provide the best therapeutic options for dry eyes. This thereby improved their revenue for the market

Ocular Pain Market Trends Impacting the Market

Now the question is which other regions Bausch & Lomb Incorporated, Novartis AG, and Sun Pharmaceutical Industries Ltd are targeting? Data Bridge Market Research has forecasted a large growth in the North America ocular pain market and the market leaders targeting U.S. and Canada to be their next pocket revenue for 2021.

The global ocular pain market is becoming more competitive with companies like Bausch & Lomb Incorporated, Novartis AG, and Sun Pharmaceutical Industries Ltd. These are the top dominating companies and have launched novel products, services, and consumables in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global ocular pain market.

For more analysis on the global ocular pain market, request a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-ocular-pain-market

Global Ocular Pain Market Developments  

  • In November 2018, Sun Pharmaceutical Industries Ltd entered into a definitive agreement to acquire Pola Pharma Inc. The acquired company is a Japanese pharmaceutical company engaged in research and development, manufacture, sale, and distribution of branded and generic products in Japan. This acquisition has enhanced the company’s footprints in Japan and leading to increased demand and sales of products in future
  • In September 2018, Novartis AG proudly announced that the company won the Ophthalmology Vision Award (XOVA) 2018 for non-profit eye health initiatives. The award for presented to the company at Euretina 2018. All the award winners were planning to help create sustainable eye clinics, train professionals, and improve awareness among the rural population. This helped company in gaining more global recognition

Scope of the Global Ocular Pain Market

The global ocular pain market is segmented based on countries into the U.S., Canada, Mexico, U.K., Germany, Hungary, Lithuania, Austria, Ireland, Norway, Poland, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait and Rest of the Middle East and Africa. All country-based analysis of the global ocular pain market is further analyzed based on maximum granularity into further segmentation.

  • On the basis of disease type, the global ocular pain market is segmented into ocular pain with eye diseases and ocular pain without primary eye diseases. On the basis of type, the global ocular pain market is segmented into diagnosis and treatment. On the basis of application, the global ocular pain market is segmented into conjunctivitis, corneal abrasion, blepharitis, sty, iritis, sinusitis, migraines, glaucoma, and others. On the basis of route of administration, the global ocular pain market is segmented into topical, periocular, intraocular, oral, and others. On the basis of drug type, the global ocular pain market is segmented into prescription and over the counter. On the basis of population type, the global ocular pain market is segmented into adults and geriatric. On the basis of end user, the global ocular pain market is segmented into hospitals, specialty clinics, home healthcare, ophthalmology centers, ambulatory surgical centers, and others. On the basis of distribution channel, the global ocular pain market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others.

To know more about the study https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

Key Pointers Covered in Global Ocular Pain Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and overview of the ocular pain market
  • Company profiling of top eight players of Ocular pain market

Key Market Competitors Covered in the Report

  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
  • Akorn Operating Company LLC
  • AERIE PHARMACEUTICALS, INC.
  • Sun Pharmaceutical Industries Ltd
  • Bausch & Lomb Incorporated
  • Ocular Therapeutix, Inc.
  • Kala Pharmaceuticals
  • Novartis AG
  • Omeros Corporation
  • Allergan (An AbbVie Company)
  • SiteOne Therapeutics, Inc.
  • Sylentis
  • Pharmaleads SA
  • Formosapharma Pharmaceutical Inc.
  • Fera Pharmaceuticals
  • Vyluma
  • TALLC Inc.
  • IACTA Pharmaceuticals, Inc.
  • Allakos Inc.
  • Aldeyra Therapeutics, Inc.
  • OKYO Pharma Limited
  • Tarsier Pharma Ltd
  • Novaliq GmbH

Above are the key players covered in the report. To know about more an exhaustive list of ocular pain companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-ocular-pain-market

Research Methodology: Global Ocular Pain Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Oncologists, Healthcare Industry, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/


Client Testimonials